The document from Courage Against Cancer discusses the integration of genomic sequencing and microbiome testing in cancer treatment. It covers potential risks, clinical limitations, ethical considerations, and patient empowerment in navigating dual testing. While offering valuable insights, it stresses the importance of informed decision-making and equitable access in cancer care.
